BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -13.05%65.22M | 1.35%345.77M | 10.83%247.35M | 9.70%158.08M | 17.98%75.01M | 23.77%341.17M | 10.85%223.18M | 9.46%144.1M | 25.76%63.58M | 21.74%275.65M |
Operating revenue | -13.05%65.22M | 1.35%345.77M | 10.83%247.35M | 9.70%158.08M | 17.98%75.01M | 23.77%341.17M | 10.85%223.18M | 9.46%144.1M | 25.76%63.58M | 21.74%275.65M |
Total operating cost | 20.47%63.66M | 17.57%287.71M | 20.18%191.6M | 19.24%118.81M | 16.15%52.84M | 33.18%244.72M | 20.81%159.43M | 15.48%99.64M | 23.52%45.49M | 21.93%183.76M |
Operating cost | 26.86%37.8M | 12.30%176.03M | 12.79%107.82M | 6.12%63.99M | 16.22%29.8M | 42.83%156.75M | 23.15%95.59M | 19.76%60.3M | 28.55%25.64M | 22.59%109.74M |
Operating tax surcharges | -17.51%822.8K | 14.63%3.69M | 32.82%2.62M | 35.37%1.83M | 9.90%997.49K | 8.96%3.22M | -17.01%1.97M | -14.38%1.35M | 33.41%907.66K | 41.39%2.96M |
Operating expense | -12.41%1.83M | 25.22%10M | 29.86%11.37M | 28.89%7.48M | -15.91%2.09M | -17.46%7.99M | 29.30%8.75M | 30.37%5.8M | 33.56%2.49M | 15.12%9.67M |
Administration expense | 3.66%9.15M | 6.42%37.63M | 3.74%27.57M | 16.80%19.26M | 19.89%8.83M | 41.00%35.35M | 38.35%26.58M | 31.42%16.49M | 31.55%7.36M | 12.36%25.07M |
Financial expense | 85.83%-379.26K | 40.92%-4.92M | 19.89%-4.31M | -14.71%-3.4M | -17,800.38%-2.68M | -3,148.79%-8.33M | -2,168.87%-5.38M | -934.12%-2.96M | -91.96%15.12K | -80.62%273.2K |
-Interest expense (Financial expense) | 690.70%172.32K | 88.06%288.1K | 111.02%182.66K | -11.04%54.88K | -60.18%21.79K | -75.32%153.19K | -412.97%-1.66M | -85.91%61.69K | -72.06%54.72K | -62.41%620.84K |
-Interest Income (Financial expense) | 78.02%-593.49K | 37.87%-5.29M | 16.52%-4.57M | -19.37%-3.54M | -3,235.48%-2.7M | -4,870.66%-8.52M | -4,925.67%-5.48M | -6,421.02%-2.96M | -225.24%-80.97K | -129.12%-171.32K |
Research and development | 4.54%14.43M | 31.25%65.28M | 45.80%46.54M | 58.94%29.65M | 51.99%13.8M | 38.03%49.74M | 24.09%31.92M | 9.76%18.66M | 6.10%9.08M | 33.65%36.04M |
Credit Impairment Loss | 81.83%-530.97K | -28.49%-11.14M | -50.38%-10.98M | -55.25%-8.34M | -111.41%-2.92M | -69.49%-8.67M | -47.52%-7.3M | -98.29%-5.37M | 46.40%-1.38M | -550.91%-5.11M |
Asset Impairment Loss | -27.78%-2.9M | -2.66%-6.34M | -73.32%-8.78M | -92.65%-6.1M | -11.83%-2.27M | -1.59%-6.18M | -17.65%-5.07M | -7.79%-3.17M | -155.60%-2.03M | -37.16%-6.08M |
Adjustment items of total operating cost | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
Other net revenue | ||||||||||
Fair value change income | 387.95%1.22M | -142.21%-814.56K | -88.17%311.85K | -186.00%-1.05M | -1,224.64%-423.05K | 693.35%1.93M | 685.11%2.64M | 327.46%1.22M | -86.55%37.62K | -24.32%243.26K |
Invest income | -57.27%1.68M | 55.60%14.39M | 120.97%10.25M | 546.81%7.88M | 663.49%3.92M | 199.14%9.25M | 107.56%4.64M | -25.78%1.22M | -6.49%513.88K | 260.66%3.09M |
-Including: Investment income associates | -293.84%-1.35M | -497.66%-2.55M | -19,240.08%-2.27M | -9,163.38%-1.07M | ---343.24K | 8,441.15%642.02K | 43.00%11.84K | 209.17%11.84K | ---- | -68.93%7.52K |
Asset deal income | ---- | -98.27%5.2K | -97.75%4.05K | ---- | ---- | --300.63K | --179.91K | ---- | ---- | ---- |
Other revenue | 167.25%1.8M | -70.76%3.72M | -68.97%2.44M | -71.93%1.77M | 187.83%673.06K | 473.88%12.73M | 675.92%7.88M | 595.03%6.31M | -54.89%233.84K | -53.26%2.22M |
Operating profit | -86.64%2.83M | -45.30%57.88M | -26.55%49.01M | -25.17%33.43M | 36.84%21.15M | 22.69%105.81M | 4.74%66.72M | 4.97%44.68M | 32.11%15.46M | 10.10%86.24M |
Add:Non operating Income | ---- | --0.26 | --1.9K | --1.9K | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Non operating expense | ---- | 1,196.94%1.51M | 1,072.51%1.36M | 8,378.04%1.31M | 21,312.29%1.3M | 69.59%116.52K | 157.42%115.59K | -55.90%15.4K | -45.06%6.08K | -4.35%68.71K |
Total profit | -85.76%2.83M | -46.67%56.37M | -28.45%47.65M | -28.06%32.13M | 28.46%19.85M | 22.65%105.69M | 4.63%66.6M | 5.02%44.66M | 32.18%15.45M | 10.11%86.18M |
Less:Income tax cost | -190.29%-964.71K | -92.32%718.34K | -58.90%2.44M | -65.39%1.51M | -1.34%1.07M | 86.31%9.35M | -2.67%5.92M | 10.11%4.36M | 69.48%1.08M | -39.14%5.02M |
Net profit | -79.81%3.79M | -42.24%55.65M | -25.48%45.22M | -24.02%30.62M | 30.70%18.78M | 18.71%96.34M | 5.40%60.68M | 4.50%40.3M | 30.03%14.37M | 15.92%81.16M |
Net profit from continuing operation | -79.81%3.79M | -42.24%55.65M | -25.48%45.22M | -24.02%30.62M | 30.70%18.78M | 18.71%96.34M | 5.40%60.68M | 4.50%40.3M | 30.03%14.37M | 15.92%81.16M |
Net profit of parent company owners | -79.81%3.79M | -42.24%55.65M | -25.48%45.22M | -24.02%30.62M | 30.70%18.78M | 18.71%96.34M | 5.40%60.68M | 4.50%40.3M | 30.03%14.37M | 15.92%81.16M |
Earning per share | ||||||||||
Basic earning per share | -80.00%0.02 | -47.37%0.3 | -35.14%0.24 | -38.46%0.16 | -28.57%0.1 | -29.63%0.57 | -36.21%0.37 | -33.33%0.26 | 27.27%0.14 | 15.71%0.81 |
Diluted earning per share | -80.00%0.02 | -47.37%0.3 | -35.14%0.24 | -38.46%0.16 | -28.57%0.1 | -29.63%0.57 | -36.21%0.37 | -33.33%0.26 | 27.27%0.14 | 15.71%0.81 |
Other composite income | 23.16%-396.46K | -70.30%-2.11M | -81.95%-1.36M | -20.90%-906.05K | -515.97K | -17.12%-1.24M | -2.62%-749.44K | -74.95%-749.44K | -1,042.18%-1.06M | |
Other composite income of parent company owners | 23.16%-396.46K | -70.30%-2.11M | -81.95%-1.36M | -20.90%-906.05K | ---515.97K | -17.12%-1.24M | -2.62%-749.44K | -74.95%-749.44K | ---- | -1,042.18%-1.06M |
Total composite income | -81.41%3.39M | -43.71%53.54M | -26.82%43.85M | -24.87%29.71M | 27.11%18.26M | 18.73%95.1M | 5.44%59.93M | 3.71%39.55M | 30.03%14.37M | 14.22%80.1M |
Total composite income of parent company owners | -81.41%3.39M | -43.71%53.54M | -26.82%43.85M | -24.87%29.71M | 27.11%18.26M | 18.73%95.1M | 5.44%59.93M | 3.71%39.55M | 30.03%14.37M | 14.22%80.1M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
Auditor | -- | -- | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.